Published by
Integral Molecular Announces Best-in-Class Antibodies Against Complex Oncology Target Claudin 18.2
PHILADELPHIA – Integral Molecular, the leader in discovering antibodies against multipass membrane proteins, announces fully optimized, high-affinity lead monoclonal antibodies (MAbs) against Claudin 18.2 […]
